Literature DB >> 21077496

A comparison of pregnancy rates following fresh and frozen embryo transfer according to the use of leuprolide acetate vs ganirelix vs cetrorelix.

J H Check1, C Wilson, J K Choe, J Amui, B Katsoff.   

Abstract

PURPOSE: To determine if controlled ovarian hyperstimulation (COH) regimens using the gonadotropin releasing hormone (GnRH) agonist leuprolide acetate result in higher pregnancy and implantation rates than COH regimens using the GnRH antagonists cetrorelix or ganirelix following fresh and frozen embryo transfer.
METHODS: Retrospective analysis was performed evaluating the pregnancy rates with the first fresh and first frozen embryo transfer cycles according to which protocol was used. A haphazard decision was made on which protocol to use. Women were required to be < 40 years of age and have had > or = 5 eggs retrieved.
RESULTS: Significantly lower implantation rates were seen with ganirelix compared to leuprolide acetate or cetrorelix.
CONCLUSIONS: These data should hopefully encourage interest in a prospective study to determine if conclusions about the inferiority of ganirelix are not merely fortuitous.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21077496

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  2 in total

1.  [Effects of cetrorelix versus ganirelix in gonadotropin-releasing hormone antagonist cycles for preventing premature luteinizing hormone surges and on clinical outcomes of IVF-ET cycles].

Authors:  Jun Zhang; Xingyu Zhou; Yingxue Chen; Qingyan Zhang; Ying Li; Jing Zhe; Xin Chen; Shiling Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-10-30

2.  Preimplantation Genetic Screening and The Success Rate of In Vitro Fertilization: A Three-Years Study on Iranian Population.

Authors:  Mehdi Totonchi; Babak Babaabasi; Hadi Najafi; Mojtaba Rezazadeh Valojerdi; Poopak Eftekhari-Yazdi; Lila Karimian; Navid Almadani; Anahita Mohseni Meybodi; Morteza Kimiai; Mehri Mashayekhi; Tahereh Madani; Hamid Gourabi
Journal:  Cell J       Date:  2020-04-22       Impact factor: 2.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.